Three months after a peer-reviewed journal cleared Cassava Sciences of data manipulation charges, the Texas-based company is fighting back.
Cassava has filed a lawsuit in federal court against individuals who were linked to a Citizen’s Petition filed with the FDA that raised concerns about data manipulation in the company’s clinical investigation of experimental Alzheimer’s treatment, simufilam.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,